Data / Form D filings / Kolon TissueGene, Inc.
Kolon TissueGene, Inc.: Form D filings
Kolon TissueGene, Inc., a biotechnology company in Rockville, MD, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on June 5, 2024, reports $35 million sold of a $35 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9713 KEY WEST AVENUE, SUITE 300, Rockville, MD, 20850
- Phone
- (301) 921-6000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1326507
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | New notice | $34,999,709 | $34,999,709 | 1 | May 23, 2024 | sec.gov | |
| May 15, 2023 | New notice | $30,000,024 | $30,000,024 | 1 | May 9, 2023 | sec.gov | |
| Aug 29, 2022 | New notice | $29,637,774 | $29,637,774 | 2 | Aug 26, 2022 | sec.gov | |
| Dec 16, 2021 | New notice | $30,089,592 | $30,089,592 | 2 | Dec 10, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Soon-Wook Joon Kweon | Executive Officer | |
| Yonggyun Joon Jeong | Executive Officer | |
| Gun Young Joon Park | Executive Officer | |
| Sun Jin Joon Kim | Executive Officer | |
| Jung In Kim | Executive Officer, Director | |
| Sun Joo Lee | Director | |
| Charles Joon Nye | Executive Officer | |
| Young Joon Kim | Executive Officer | |
| Diana Halim | Executive Officer | |
| Moon Jong Noh | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kolon TissueGene, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.